Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent.
Capizzi
R L
RL
Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
D004999:Amifostine / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy; D019610:Cytoprotection; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D020011:Protective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011837:Radiation-Protective Agents / Q000627:therapeutic use
D000970:Antineoplastic Agents; D020011:Protective Agents; D011837:Radiation-Protective Agents; D004999:Amifostine